Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 modulates microglial activity through regulation of chemokine (C–X3–C) receptor 1 –mediated signalling pathways
Bo Ma, Leyan Xu, Xiaodong Pan, et al.
Human Molecular Genetics (2016) Vol. 25, Iss. 16, pp. 3515-3523
Open Access | Times Cited: 49

Showing 26-50 of 49 citing articles:

Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease
Beatrice Weykopf, Simone Haupt, Johannes Jungverdorben, et al.
European Journal of Neuroscience (2019) Vol. 49, Iss. 4, pp. 561-589
Open Access | Times Cited: 24
The impact of murine LRRK2 G2019S transgene overexpression on acute responses to inflammatory challenge
Darcy Litteljohn, Chris Rudyk, Zach Dwyer, et al.
Brain Behavior and Immunity (2017) Vol. 67, pp. 246-256
Closed Access | Times Cited: 22
LRRK2 Phosphorylation: Behind the Scenes
Tina De Wit, Veerle Baekelandt, Evy Lobbestael
The Neuroscientist (2018) Vol. 24, Iss. 5, pp. 486-500
Closed Access | Times Cited: 20
Metabolomics in Parkinson's disease
Jacopo Troisi, Annamaria Landolfi, Pierpaolo Cavallo, et al.
Advances in clinical chemistry (2020), pp. 107-149
Closed Access | Times Cited: 17
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity
Salvatore Novello, Daniela Mercatelli, Federica Albanese, et al.
Neurobiology of Disease (2021) Vol. 162, pp. 105579-105579
Open Access | Times Cited: 16
Microglial LRRK2‐mediated NFATc1 attenuates α‐synuclein immunotoxicity in association with CX3CR1‐induced migration and the lysosome‐initiated degradation
Linjuan Feng, Hsuan Lo, Zhaoxiang Hong, et al.
Glia (2023) Vol. 71, Iss. 9, pp. 2266-2284
Closed Access | Times Cited: 6
Co-administration of TiO2-nanowired dl-3-n-butylphthalide (dl-NBP) and mesenchymal stem cells enhanced neuroprotection in Parkinson's disease exacerbated by concussive head injury
Feng Niu, Aruna Sharma, Zhenguo Wang, et al.
Progress in brain research (2020), pp. e3-e4
Closed Access | Times Cited: 16
Microglia depletion prior to lipopolysaccharide and paraquat treatment differentially modulates behavioral and neuronal outcomes in wild type and G2019S LRRK2 knock-in mice
Zach Dwyer, Chris Rudyk, Divya Situt, et al.
Brain Behavior & Immunity - Health (2020) Vol. 5, pp. 100079-100079
Open Access | Times Cited: 13
The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson’s Disease
Mengfei Zhang, Chaoyi Li, Jie Ren, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 9
The Parkinson's disease–associated kinase LRRK2 regulates genes required for cell adhesion, polarization, and chemotaxis in activated murine macrophages
Daniel Robert Siegfried Levy, Atul Udgata, Panagiotis Tourlomousis, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 31, pp. 10857-10867
Open Access | Times Cited: 12
How Parkinson’s Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types
Hannah M. Bailey, Mark Cookson
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 7, pp. 1331-1352
Open Access | Times Cited: 1
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
Meritxell Pons‐Espinal, Lucas Blasco-Agell, Antonella Consiglio
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 5, pp. 2081-2094
Open Access | Times Cited: 10
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years
Alice Filippini, Massimo Gennarelli, Isabella Russo
Biochemical Society Transactions (2021) Vol. 49, Iss. 3, pp. 1375-1384
Closed Access | Times Cited: 8
LRRK2 G2019S and Parkinson’s disease: insight from Neuroinflammation
Xiao-Yan Yao, Lina Guan, Qi Chen, et al.
Postgraduate Medical Journal (2023) Vol. 100, Iss. 1179, pp. 4-11
Closed Access | Times Cited: 1
Casual association between CX3CL1/CX3CR1 and Parkinson's Disease: A Mendelian randomization and Colocalization study
Shan Zeng, Aishanjiang Yusufujiang, Hongyan Li, et al.
Research Square (Research Square) (2024)
Open Access
Microglia depletion prior to lipopolysaccharide and paraquat treatment differentially modulates behavioral and neuronal outcomes in wild type and G2019S LRRK2 knock-in mice.
Zach Dwyer, Chris Rudyk, Divya Situt, et al.
Research Square (Research Square) (2019)
Open Access | Times Cited: 2
Pathologic α-Synuclein Species Activate LRRK2 in Pro-Inflammatory Monocyte and Macrophage Responses
Enquan Xu, Ravindra Boddu, Hisham Abdelmotilib, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Leucine-rich repeat kinase 2 (LRRK2) and Parkinson's disease: from genetics to pathobiology
Susanna Cogo, Elisa Greggio
Elsevier eBooks (2020), pp. 3-18
Closed Access | Times Cited: 1
A role for LRRK2 and Neuroinflammatory Processes in Multi-Hit Toxicant Models of Parkinson’s Disease
Chris Rudyk
(2018)
Open Access
Neuroinflammation and Parkinson’s Disease: Understanding the Inflammatory Process Induced by Chronic Peripheral Injection of LPS in LRRK2 G2019S KI Mice in Correlation with Age
Anuroopa Dinesh
(2019)
Open Access
Environmental toxicant exposure and Parkinson’s disease: LRRK2 and inflammatory processes
Zachary Dwyer
(2019)
Open Access
Biomarkers of Parkinson's Disease
Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, et al.
Elsevier eBooks (2019), pp. 895-909
Closed Access
Translocator protein 18 ligand Emapunil protects against neurodegeneration in the MPTP mouse model of Parkinsonism
Jing Gong
(2020)
Open Access
Pathogenic Factors and Treatment of Parkinson’s Disease
育辉 姜
Bioprocess (2021) Vol. 11, Iss. 04, pp. 67-75
Closed Access
Previous Page - Page 2

Scroll to top